ELN Breakfast Meeting
New Orleans, December 13, 2026
The next ELN Breakfast Meeting will take place in New Orleans on Sunday, December 13, 2026, 6-10 AM as usual.
Invitations will follow as soon as the venue in New Orleans has been confirmed, usually in late July or August.
23.ELN/26.KNL Symposium
Venice, March 11-13, 2027
The 23.ELN/26.KNL Symposium will take place at the Istituto Veneto di Science, Lettere ed Arti in Venice on Thursday, March 11, to Saturday, March 13, 2027. The Symposium will have research sessions on the various types of leukemia and interdisciplinary specialities and plenary sessions for summary reports and keynote lectures.
Invitations will follow after the ELN Breakfast Meeting in New Orleans in December 2026.
Information and invitation through info@text-event.de
ELN/KNL Symposia 2023, 2024, 2025 and 2026
Photos of the ELN/KNL Symposia 2023 and 2024 (Group Photos, Keynote Lectures, Merit Awards) can be accessed here:
XXXIII IACRLRD Symposium 2027
October 2027 - Houston, USA
President: Hagob Kantarjian
Information: generalsecretary@iacrlrd.org
Network info and goals
The ELN is an international network of excellence for cooperative research on leukemia. Ca. 220 participating centers in 45 countries (map attached) with more than 1000 researchers and clinicians are cooperating. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, treatment research, registry, guidelines), industry and SMEs to form a network promoting cooperative research for curing leukemia. A summary of the mission of ELN is attached.
Achievements of the ELN
Achievements in addition to the integration of leukemia research among its more than 1000 physicians and researchers and 220 institutions are the more than 100 management recommendations and guidelines for all types of leukemia and related interdisciplinary specialities. A selection of the recommendations 2013-2025 is included in the attachment. The key instrument of integration are regular meetings, in particular the annual ELN symposium at no cost for participants
Definition and funding of the European LeukemiaNet
The European LeukemiaNet started as a publicly funded research network of excellence. Goal is cure of leukemia by integration of leukemia research and spread of excellence. The European LeukemiaNet was funded by the 6th Framework Program of the European Community until 2011, by the European Research Foundation until 2015 and is currently funded by the ELN-Foundation.
ELN Steering Committee (ELN SC)
ELN SC members
- Jane Apperley
- Tiziano Barbui
- Marie C. Bené
- William Blum
- Lars Bullinger
- Felipe Casado
- Sabina Chiaretti
- Jacqueline Cloos
- Carlo Croce
- Nick Cross
- Michael Deininger
- Hartmut Döhner
- Hervé Dombret
- Martin Dugas
- Bianca Espinet
- Pierre Fenaux
- Robin Foa
- Robert Peter Gale
- Arnold Ganser
- Laurent Gardaret
- Paolo Ghia
- Nicola Gökbuget
- Martin Griesshammer
- Joelle Guilhot
- Francois Guilhot
- Claudia Haferlach
- Torsten Haferlach
- Jesus Hernandez
- Michael Heuser
- Andreas Hochhaus
- Dieter Hoelzer
- Jerzy Holowiecki
- Gerwin Huls
- Wiesław Jędrzejczak
- Hans-Jochem Kolb
- Alexander Kulagin
- Sergej Kulikov
- Michael Lauseker
- Weiming Li
- Per Ljungman
- Elsa Lomaia
- Francois-Xavier Mahon
- Luca Malcovati
- Giovanni Martinelli
- Michael Mauro
- Moshe Mittelman
- Ivan Moisiv
- Carsten Müller-Tidow
- Dietger Niederwieser
- Gert Ossenkoppele
- Elena Parovichnikova
- Markus Pfirrmann
- Andy Rawstron
- Josep Ribera
- Harald Rieder
- Christoph Röllig
- Gianantionio Rosti
- Tapani Ruutu
- Giuseppe Saglio
- Miguel Sanz
- Susanne Saußele
- Lydia Scarfo
- Hubert Serve
- Richard Silver
- Leif Stenke
- Isolde Summerer
- Christian Thiede
- Alessandro Vannucchi
- Theo de Witte
- Gina Zini
ELN-Coordinator
- Rüdiger Hehlmann